Skip to main content
. Author manuscript; available in PMC: 2013 Nov 22.
Published in final edited form as: J Pediatr Endocrinol Metab. 2013;26(0):10.1515/jpem-2012-0259. doi: 10.1515/jpem-2012-0259

Table 1.

Characteristics of the Study Population.

Overall population (n=176) Normal glucose tolerance (n=105) Dysglycemia (n=71) p-Value
Mean (SD) age 13.7 (2.1) 13.6 (2.1) 13.7 (2.0) 0.93
Sex, % (n)
 Female 50.0 (88) 56.2 (59) 40.9 (29)
 Male 50.0 (88) 43.8 (46) 59.1 (42) 0.05
Race,%(n)
 White 59.7 (105) 65.7 (69) 50.7 (36)
 Black 31.8 (56) 27.6 (29) 38.0 (27)
 Other 8.5 (15) 6.7 (7) 11.3 (8) 0.13
Weight status, % (n)
 Overweight (BMI ≥85th and <95th percentiles) 17.6 (31) 24.8 (26) 7.0 (5)
 Obese (BMI ≥95th percentile) 82.4 (145) 75.2 (79) 93.0 (66) <0.01
Family history of T2 D, % (n)
 First-degree relative 25.6 (45) 18.1 (19) 36.6 (26)
 Second-degree relative 46.0 (81) 46.7 (49) 45.1 (32)
 No family history 28.4 (50) 35.2 (37) 18.3 (13) <0.01
Self-report of hyperlipidemia, % (n) 11.4 (20) 12.4 (13) 9.9 (7) 0.61
Self-report of PCOSa, % (n) 3.4 (3) 1.7 (1) 6.9 (2) 0.21
Maternal history of diabetes, %(n) 10.8 (19) 8.6 (9) 14.1 (10) 0.25
% Abnormal BP (14), % (n) 29.0 (51) 28.6 (30) 29.6 (21) 0.89
% Abnormal BP using modified guidelines (15), % (n) 42.1 (74) 42.9 (45) 40.9 (29) 0.79
Presence of acanthosis nigricans, % (n) 10.2 (18) 2.9 (3) 21.1 (15) <0.01
Tanner stageb (n=134), % (n)
 1 7.5 (10) 7.3 (6) 7.7 (4)
 2 11.9 (16) 12.2 (10) 11.5 (6)
 3 22.4 (30) 24.4 (20) 19.2 (10)
 4 32.1 (43) 30.5 (25) 34.6 (18)
 5 26.1 (35) 25.6 (21) 26.9 (14) 0.97
Median (range) Tanner stage 4 (1–5) 4 (1–5) 4 (1–5)
Pubertal, % (n) 92.5 (124) 92.7 (76) 92.3 (48)
Prepubertal, % (n) 7.5 (10) 7.3 (6) 7.7 (4) 0.94
Mean (SD) random glucose, mg/dL 97.7 (16.6) 92.9 (13.7) 104.8 (18.0) <0.001
Mean (SD) 1-h glucose challenge test 113.3 (28.7) 104.0 (22.0) 127.0 (32.0) <0.001
Mean (SD) HbA1c, % 5.5 (0.5) 5.5 (0.4) 5.6 (0.5) 0.11
a

Prevalence among females only.

b

For those with self-reported pubertal measures (n=134).